Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2020 09:07 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Named 2020 Business Person of the Year by Triangle Business Journal

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
August 24, 2020 08:15 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Receives 2020 Life Sciences Award from the Triangle Business Journal

RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
August 03, 2020 09:30 ET | Source: Asklepios BioPharmaceutical, Inc.

AskBio CSO Jude Samulski Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine

RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...
June 23, 2020 09:18 ET | Source: Asklepios BioPharmaceutical, Inc.

AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System

RESEARCH TRIANGLE PARK, N.C. , June 23, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today...